Panelists discuss how the BE OPTIMAL study enrolled biologic-naive patients, whereas BE COMPLETE enrolled TNF inhibitor-inadequate responders. Both populations showed similar response rates despite ...

Overview IPOs often deliver strong short-term gains, but many underperform in the long run compared to secondary market ...

Once-daily oral brepocitinib 30 mg demonstrated clinically meaningful and statistically significant improvement compared to placebo on the primary endpoint and all nine key secondary endpoints, ...

Primary schools help children build essential skills they need to succeed throughout the rest of their education. But when it ...

A 3-year review of metrics related to primary care delivery for Medicare-eligible patients suggests that payment models that ...

New studies support surgical procedures over medication for weight management, health outcomes, and patient costs.

Background Oral anticoagulation (OAC) effectively reduces stroke risk in patients with atrial fibrillation (AF), but its use ...

Background The ‘right to request’ flexible working policy has been gradually extended and, by 2014, extended to cover all ...

Background Those with premature coronary heart disease (pCHD) have a lower 5-year risk of repeat events; however, their ...

A microsimulation model was used to evaluate the cost-effectiveness of two glucagon-like peptide-1 receptor agonists (GLP1RAs), semaglutide and tirzepatide, for patients with osteoarthritis and ...

Hospital leaders from University College Hospital and Charité-Universitatsmedizin Berlin talk about what they're doing right ...

Tirzepatide was associated with significant declines in HbA1c and BMI for children and adolescents with type 2 diabetes, according to data from the SURPASS-PEDS trial. Tamara S. Hannon, MD, professor ...